← Back to Clinical Trials
Recruiting NCT07430943

NCT07430943 Feasibility of Integrating Street Racket Into Ambulatory Pulmonary Rehabilitation

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07430943
Status Recruiting
Phase
Sponsor Mona Lichtblau
Condition Pulmonary Rehabilitation
Study Type INTERVENTIONAL
Enrollment 12 participants
Start Date 2026-03-05
Primary Completion 2027-02-28

Trial Parameters

Condition Pulmonary Rehabilitation
Sponsor Mona Lichtblau
Study Type INTERVENTIONAL
Phase N/A
Enrollment 12
Sex ALL
Min Age N/A
Max Age N/A
Start Date 2026-03-05
Completion 2027-02-28
Interventions
Street Racket

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

This study looks at whether Street Racket is a feasable activity that can be added to pulmonary rehabilitation for people with chronic lung disease. Participants complete short questionnaires at the start and end of the program to rate the feasibility and rate their breathlessness during each session. Attendance is recorded to understand how well the activity is used and whether there are any barriers.

Eligibility Criteria

Inclusion Criteria: * Any sex or gender * Age \>18 years * Prescribed APR by a physician and currently participating in APR at the USZ * Physically and psychologically capable of following instructions and standing/walking for up to one hour (short, seated breaks are allowed if needed) Exclusion Criteria: * Require supplemental oxygen therapy that cannot be delivered via a portable backpack system (e.g., large oxygen cylinders on wheels, which pose a fall risk) * Are unable to follow study procedures due to language barriers, psychological conditions, or orthopaedic limitations that prevent them from standing or walking for up to one hour * Require walking aids due to impaired balance (e.g., walking sticks, rollator, etc.)

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology